泛素连接酶
计算生物学
结构相似性
结合位点
化学相似性
化学
隐藏物
计算机科学
公共领域
药物发现
绑定域
虚拟筛选
相似性(几何)
小分子
连接器
生物化学
随机森林
领域(数学分析)
DNA连接酶
配体(生物化学)
蛋白质数据库
血浆蛋白结合
同源建模
分子动力学
分类器(UML)
泛素
生物信息学
标杆管理
生物
立体化学
结合亲和力
纳米技术
分子
靶蛋白
生物物理学
组合化学
蛋白质结构
化学空间
二硫键
作者
Madhushika Silva,Oleksandra Herasymenko,Abd Al‐Aziz A. Abu‐Saleh,Suzanne Z. Ackloo,Rima Al‐awar,C.H. Arrowsmith,Ryota Ashizawa,David J. Bearss,Beck Hartmut,Kevin P. Bishop,Vincent Blay,Hugo J. Bohórquez,Albina Bolotokova,Duanhua Cao,Irene Chau,Lin Chen,Sandro Cosconati,Wim Dehaen,Kristina Edfeldt,Elisa Gibson
标识
DOI:10.1021/acs.jcim.6c02396
摘要
Abstract The critical assessments of computational hit-finding experiments (CACHE) are prospective benchmarking exercises where small molecule ligands predicted for a nominated protein of interest are procured and tested experimentally. In CACHE #4, 23 participating teams each selected up to 100 compounds designed to bind the E3 ligase CBLB, an immuno-oncology target. The organizers released the first public structure of CBLB in complex with a known ligand at the outset of the challenge to enable the discovery of chemically novel molecules. Out of the 1688 compounds collectively predicted, ten compounds from nine participants showed some sign of activity (primary hits), but only two were convincingly confirmed (validated hits) across multiple biophysical binding assays and in subsequent analogs, and only one of them was chemically novel. The apparent difficulty of finding novel CBLB ligands, previously reflected by the chemical similarity of inhibitors from the patent literature, suggests that potent CBLB hit molecules were either rare in the screened commercial libraries, or that computational methods may have struggled to retrieve presumably present but weak ligands, or that the conformational dynamics of the binding site was not sufficiently accounted for. The successful method was strikingly atypical. Selection from a chemical binding similarity classifier followed by a random forest binding affinity predictor trained on inhibitors from the patent literature was refined using a diffusion-model binding pose predictor. The road to an ML-driven breakthrough in computational hit-finding can take unexpected turns. Which of these turns reveal novel horizons and which are mere distractions will best be investigated and answered collectively. The discovery in CACHE #4 of a novel series of CBLB ligands is not a trivial achievement and may inform medicinal chemistry efforts toward clinical candidates that complement immune checkpoint inhibition to elicit antitumor immune response in cancer patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI